Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04597671
Title Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) (NVALT28)
Acronym NVALT28
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Association NVALT Studies
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD


No variant requirements are available.